Proposal for a New Morphological "combined Type" of Gallbladder Cancer: Description of Radiopathological Characteristics and Comparison with Other Morphological Types
Overview
Radiology
Authors
Affiliations
Objective: To describe the radiopathological characteristics of a new morphological "combined type" of gallbladder cancer (GBC) and compare it with the mass replacing gallbladder and thickening types of GBC.
Materials And Methods: The imaging and pathological details of consecutive patients with GBC between August 2020 and December 2022 were retrospectively reviewed. Two radiologists reviewed computed tomography/magnetic resonance imaging in consensus for the morphological type of GBC. The radiologists classified GBC as mass replacing gallbladder, wall thickening, and combined type. The combined type was defined as a mass arising from the thickened wall of an adequately distended gallbladder that extended exophytically into the adjacent liver parenchyma. The presence of calculi, site, and size of lesion, biliary/portal vein involvement, liver, lymph node, and omental metastases was compared among the various types. The pathological characteristics were also compared.
Results: Of the 481 patients (median age 55 years, 63.2% females) included in the study, mass replacing gallbladder, wall thickening, and combined-type GBC were seen in 42.8% (206/481), 40.5% (195/481), and 16.6% (80/481) of patients, respectively. In the combined type of GBC, biliary/portal vein involvement was seen in 63.7% (51/80) and 7.5% (6/80) of patients. Liver, lymph node, and omental metastases were seen in 67.5% (54/80), 40% (32/80), and 41.2% (33/80) patients, respectively. Liver metastases were significantly more common in the combined type (p = 0.002). There were no significant differences in pathological characteristics among the various types.
Conclusion: Combined-type GBC is less common than the mass replacing gallbladder and thickening types and is associated with a higher risk of liver metastases.
Kalage D, Sajjana G, Hegde S, Gulati A, Yadav T, Kaman L J Clin Exp Hepatol. 2024; 14(6):102377.
PMID: 39183738 PMC: 11342763. DOI: 10.1016/j.jceh.2024.102377.
Gallbladder cancer: Progress in the Indian subcontinent.
Kumar A, Sarangi Y, Gupta A, Sharma A World J Clin Oncol. 2024; 15(6):695-716.
PMID: 38946839 PMC: 11212610. DOI: 10.5306/wjco.v15.i6.695.
Gupta P, Kambadakone A, Sirohi B Front Oncol. 2024; 14:1387531.
PMID: 38567157 PMC: 10985351. DOI: 10.3389/fonc.2024.1387531.